Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Jul 26;32(25):1170-4.

[Which antithrombotic treatment should be used in the treatment of an elderly patient with chronic atrial fibrillation?]

[Article in French]
I Mahé  1 , A S Grenard, C Caulin, J F Bergmann
Affiliations
  • PMID: 13677880
Review

[Which antithrombotic treatment should be used in the treatment of an elderly patient with chronic atrial fibrillation?]

[Article in French]
I Mahé et al. Presse Med. .

Abstract

FREQUENCY AND CONSEQUENCES: The incidence of atrial fibrillation (AF) increases regularly with age and affects nearly 10% of persons aged over 80. The risk of thromboembolism (notably stroke) associated is enhanced the older the patient and the more cardiovascular risk factors she/he exhibits. ADVANTAGES AND RISKS OF ANTICOAGULANTS: Treatment with anticoagulants is the only treatment that has demonstrated its efficacy in reducing the risks of thromboembolism, however there is a risk of haemorrhage.

In practice: A patient with AF exhibits both a risk of thromboembolism and a risk of haemorrhage. When confronted with such patients, the practitioner must choose an antithrombotic (anticoagulant or anti-arrhythmic agent) after careful objective and individual assessment of all the risks present in a given patient.

PubMed Disclaimer

MeSH terms

LinkOut - more resources